Clinical Trials Logo

Clinical Trial Summary

The evidence demonstrating the importance of coronary microcirculation in the management of patients with coronary artery disease is growing. For example, in recent years, a number of studies have demonstrated that the presence of coronary microvascular disease (CMVD) contributes to increased cardiovascular morbidity and mortality independent of the extent and severity of coronary epicardial disease. The index of microcirculatory resistance (IMR) is an invasive index proposed for the diagnosis of CMVD. The ability of IMR to motivate therapeutic changes in order to subsequently reduce symptoms and improves the quality of life of our patients with stable coronary artery disease (CAD) was recently demonstrated. The prognostic value of IMR has also been shown in stable CAD with PCI. Thus, after optimal epicardial revascularization, IMR could represent a tool for personalized medicine adapted to the presence of severe CMVD. The aim of the study is to to demonstrate a positive effect of personalized medicine on angina in patients with epicardial revascularization by PCI and with significant CMVD assessed by IMR.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05178914
Study type Interventional
Source University Hospital, Grenoble
Contact Gilles Barone Rochette
Phone +33476765172
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date March 2022
Completion date March 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04614467 - A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction Phase 2
Recruiting NCT04598997 - Artificial Intelligence With DEep Learning on COROnary Microvascular Disease
Completed NCT03104062 - Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction N/A
Completed NCT04202172 - Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial) Phase 4
Active, not recruiting NCT03523624 - Factor XIII and Other Biomarkers in ST Segment Elevation Myocardial Infarction
Completed NCT02045459 - Microvascular Disease Exercise Trial N/A
Recruiting NCT04005963 - The Value of PET Quantitative Analysis of Coronary Physiology in Coronary Microvascular Disease
Recruiting NCT03064295 - Whole-Heart Myocardial Blood Flow Quantification Using MRI
Recruiting NCT03537586 - A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction N/A
Recruiting NCT04960371 - Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients
Not yet recruiting NCT04554004 - A Non-invasive Index of Microciculatory Resistance N/A
Not yet recruiting NCT04440761 - Barts-MINOCA Registry
Recruiting NCT04685941 - Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia N/A
Not yet recruiting NCT04220372 - Tongxinluo Capsule for Coronary Microvascular Disease Phase 4
Not yet recruiting NCT04218916 - Rhodiola Rosea for Coronary Microvascular Disease Phase 2/Phase 3
Recruiting NCT04186676 - Myocardial Infarction With Non-Obstructive Coronary Arteries in the Greek Population
Completed NCT02910154 - Comprehensive Treatment of Angina in Women With Microvascular Dysfunction N/A
Recruiting NCT03917251 - The Effects of Trans Venous Cardiac Pacing on Coronary Microvascular Function and Hemodynamics N/A
Terminated NCT04321434 - Hyperoxia and Microvascular Dysfunction N/A
Recruiting NCT04606459 - COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina N/A